A Novel Multivalent OspA Vaccine against Lyme Borreliosis

The new Lyme vaccine -http://cvi.asm.org/content/early/2014/08/29/CVI.00406-14.abstract?maxtoshow=&hits=2&RESULTFORMAT=&andorexacttitle=and&andorexacttitleabs=and&fulltext=Lyme&andorexactfulltext=and&searchid=1&usestrictdates=yes&resourcetype=HWCIT&ct

A Novel Multivalent OspA Vaccine against Lyme Borreliosis is Safe and Immunogenic in an Adult...

Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to re-infection with Borrelia burgdorferi sensu lato (s.l.). There is limited information available about OspA vaccines in this population. In this study, a randomized, double—blind…

CVI.ASM.ORG